SEC CIK 1753557
Marrs Anna
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| AXPview stock → | 47,818.52 | 2026-02-05 |
| DOCUview stock → | 13,525 | 2026-09-14 |
Position History — AXP
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — AXP
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-02-05 | Option exercise (derivative) | 14,992 | $0.00 | 0 |
| 2026-02-05 | Option exercise | 14,992 | $173.61 | 47,818.52 |
| 2026-02-05 | Open-market sale | 27,425 | $350.01 | 20,393.52 |
| 2026-02-01 | Grant / award (derivative) | 14,992 | $0.00 | 14,992 |
| 2026-02-01 | Tax withholding | 829 | $352.17 | 32,826.52 |
| 2026-02-01 | Grant / award | 24,883 | — | 45,276.52 |
| 2026-02-01 | Tax withholding | 13,637 | $352.17 | 31,639.52 |
| 2026-02-01 | Grant / award | 2,016 | — | 33,655.52 |
| 2025-10-31 | Grant / award (derivative) | 67,365 | $0.00 | 67,365 |
| 2025-07-29 | Open-market sale | 5,500 | $310.77 | 20,311.21 |
| 2025-03-04 | Option exercise (derivative) | 16,274 | $0.00 | 0 |
| 2025-03-04 | Open-market sale | 2,300 | $286.68 | 41,041.53 |
| 2025-03-04 | Open-market sale | 5,681 | $291.50 | 25,760.53 |
| 2025-03-04 | Open-market sale | 301 | $287.78 | 31,741.53 |
| 2025-03-04 | Open-market sale | 300 | $290.76 | 31,441.53 |
| 2025-03-04 | Open-market sale | 697 | $285.51 | 43,341.53 |
| 2025-03-04 | Open-market sale | 3,677 | $285.00 | 44,038.53 |
| 2025-03-04 | Option exercise | 16,274 | $177.06 | 47,715.53 |
| 2025-03-04 | Open-market sale | 8,999 | $287.18 | 32,042.53 |
| 2025-01-28 | Grant / award (derivative) | 16,274 | $0.00 | 16,274 |
| 2025-01-28 | Tax withholding | 13,035 | $316.42 | 31,409.79 |
| 2025-01-28 | Grant / award | 24,398 | $316.42 | 44,444.79 |
| 2024-05-03 | Option exercise (derivative) | 2,240 | $0.00 | 0 |
| 2024-05-03 | Open-market sale | 3,592 | $230.93 | 19,932.35 |
| 2024-05-03 | Option exercise | 2,240 | $153.35 | 23,524.35 |
| 2024-04-30 | Grant / award (derivative) | 2,240 | $0.00 | 2,240 |
| 2024-04-30 | Grant / award | 3,025 | $238.92 | 22,957.35 |
| 2024-04-30 | Tax withholding | 1,673 | $238.92 | 21,284.35 |
| 2024-02-12 | Option exercise (derivative) | 25,039 | $0.00 | 0 |
| 2024-02-12 | Option exercise | 25,039 | $116.26 | 56,180.31 |
| 2024-02-12 | Open-market sale | 36,279 | $212.99 | 19,901.31 |
| 2024-01-29 | Grant / award (derivative) | 25,039 | $0.00 | 25,039 |
| 2024-01-29 | Grant / award | 31,927 | $201.43 | 48,077.31 |
| 2024-01-29 | Tax withholding | 16,936 | $201.43 | 31,141.31 |
| 2023-02-14 | Option exercise (derivative) | 30,971 | $0.00 | 0 |
| 2023-02-14 | Open-market sale | 30,261 | $179.19 | 29,422.72 |
| 2023-02-14 | Option exercise | 30,971 | $131.68 | 59,683.72 |
| 2023-02-14 | Open-market sale | 13,400 | $180.19 | 16,022.72 |
| 2023-01-29 | Grant / award (derivative) | 30,971 | $0.00 | 30,971 |
| 2023-01-29 | Grant / award | 28,189 | $172.31 | 43,916.76 |
| 2023-01-29 | Tax withholding | 15,228 | $172.31 | 28,688.76 |
| 2022-02-04 | Open-market sale | 6,700 | $184.55 | 15,642 |
| 2022-01-31 | Open-market sale (derivative) | 29,982 | $177.14 | 2,966 |
| 2022-01-31 | Grant / award (derivative) | 32,948 | $0.00 | 32,948 |
| 2022-01-31 | Option exercise (derivative) | 29,982 | $0.00 | 2,966 |
| 2022-01-31 | Open-market sale | 29,982 | $177.14 | 19,376 |
| 2022-01-31 | Option exercise | 29,982 | $100.96 | 49,358 |
| 2022-01-31 | Option exercise (derivative) | 32,948 | $0.00 | 0 |
| 2022-01-31 | Open-market sale | 29,982 | $177.14 | 22,342 |
| 2022-01-31 | Option exercise | 32,948 | $100.96 | 52,324 |
| 2022-01-29 | Grant / award | 30,507 | $177.06 | 36,482 |
| 2022-01-29 | Disposition to issuer | 17,106 | $177.06 | 19,376 |
| 2022-01-29 | Disposition to issuer | 17,106 | $177.06 | 19,376 |
| 2022-01-29 | Grant / award | 30,507 | $0.00 | 36,482 |
| 2022-01-29 | Grant / award (derivative) | 32,948 | $0.00 | 32,948 |
| 2022-01-29 | Tax withholding | 17,106 | $177.06 | 19,376 |
| 2022-01-29 | Grant / award | 30,507 | $0.00 | 36,482 |
| 2021-11-24 | Option exercise (derivative) | 21,572 | $0.00 | 0 |
| 2021-11-24 | Option exercise | 21,572 | $102.73 | 32,069 |
| 2021-11-24 | Open-market sale | 19,880 | $171.22 | 12,189 |
| 2021-11-24 | Open-market sale | 6,214 | $171.22 | 5,975 |
| 2021-10-31 | Grant / award (derivative) | 21,572 | $0.00 | 21,572 |
| 2021-10-31 | Tax withholding | 13,007 | $173.78 | 8,565 |
| 2021-10-31 | Grant / award | 4,867 | $173.78 | 13,432 |
| 2021-10-31 | Tax withholding | 2,935 | $173.78 | 10,497 |
| 2021-10-31 | Grant / award | 21,572 | $173.78 | 21,572 |
| 2020-11-10 | Open-market sale | 2,064 | $119.56 | 0 |
| 2020-10-31 | Grant / award | 4,867 | $91.24 | 4,867 |
| 2020-10-31 | Tax withholding | 2,803 | $91.24 | 2,064 |
| 2018-09-10 | — | — | — | 0 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.